Kura Oncology, Inc.·4

Sep 17, 4:10 PM ET

VASCONCELLES MICHAEL 4

4 · Kura Oncology, Inc. · Filed Sep 17, 2024

Insider Transaction Report

Form 4
Period: 2024-09-13
Transactions
  • Award

    Option to purchase common stock

    2024-09-13+52,00052,000 total
    Exercise: $20.88Exp: 2034-09-12Common Stock (52,000 underlying)
  • Award

    Option to purchase common stock

    2024-09-13+17,33317,333 total
    Exercise: $20.88Exp: 2034-09-12Common Stock (17,333 underlying)
Footnotes (2)
  • [F1]This option vests in three equal annual installments commencing on the one year anniversary of the date of grant.
  • [F2]This option vests in full on the one year anniversary of the date of grant.

Documents

1 file
  • 4
    ownership.xmlPrimary

    4